483
Row1 Inc. dba Regenative LabsRow1 Inc. dba Regenative Labs – FDA 483, Mar 30, 2022
Record Details
Rowl Inc. dba Regenative Labs in Pensacola, FL, was cited for significant deficiencies during an FDA inspection of its human tissue establishment. The inspection revealed widespread issues with aseptic processing, process validation, environmental monitoring, and quality control for its umbilical cord tissue products. These findings indicate a severe lack of adherence to regulations designed to ensure product sterility, identity, strength, quality, and purity.
View Company Profile
ID · 566c2f3c-a7e2-4bd8-b584-97b5760d6858
Other documents for Row1 Inc. dba Regenative Labs
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.